Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Auris Medical Holding AG

NASDAQ: EARSHealthcare / Biotechnology / Switzerland
0.360000.00Vol 426 7281Y Perf -86.36%
Feb 21st, 2019 16:00
BID0.3600 ASK0.3600
Open0.3700 Previous Close0.3600
Pre-Market- After-Trading-
 - -%  - -%
Target Price
2.50 
Analyst Rating
— 0.00
Potencial %
594.44 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)13 
Earnings Rating
Neutral
Price Range Ratio 52wk %
4.23 
Earnings Date
28th Mar 2019

Today's Price Range

0.36000.3700

 

52wk Range

0.23003.30

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
-10.00%
3 Months
-40.00%
6 Months
33.33%
1 Year
-86.36%
3 Years
-99.15%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
EARS0.36000.00000.00
AAPL171.06-0.9700-0.56
GOOG1 096.97-16.8300-1.51
MSFT109.412.26002.11
XOM77.82-0.7100-0.90
WFC49.56-0.2500-0.50
JNJ135.42-0.9300-0.68
FB160.04-2.5200-1.55
GE10.03-0.0700-0.69
JPM105.47-0.2200-0.21
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
0.80
Current Ratio
0.90
Long Term Debt to Total Capital
-
Total Debt to Equity
-
Interest Coverage
-8.10
Leverage Ratio -5.50
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-
EBITDA Margin
-
Pre-tax Profit Margin
-
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
6.52
PS Ratios
-
Price to Cash Flow
-
Price to Free Cash Flow
-1.20
Cash Flow Per Share
-1.88
Price to Tangible Book
-18.96
Book Value per Share
-0.02
Enterprise Value (in ths.)
11 205
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-99.22
ROE last 12 Months
2 036.61
Return on Assets (5Y Avg)
-153.67
ROA last 12 Months
-80.26
Return on Capital (5Y Avg)
-91.08
ROC last 12 Months
-
Return on invested Capital Q
-
Return on invested Capital Y
-132.42
Assets Turnover
0.00
Receivables Turnover
0.00
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
0
Revenue per Share
0.00
Revenue Growth 3 Years
-
Revenue Growth 5 Years
-
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018--0.14-
Q04 2017--1.01-
Q03 2017-2.00-1.5025.00
Q02 2017-2.10-1.2042.86
Q01 2017-0.10-0.22-120.00
Q04 2016-0.22-0.1627.27
Q03 2016-0.28-0.2317.86
Q02 2016-0.26-0.260.00
Earnings Per EndEstimateRevision %Trend
9/2017 QR-0.200.00-
12/2017 QR-0.140.00-
12/2018 FY-0.4212.50Positive
12/2019 FY-0.3120.51Positive
Next Report Date28th Mar 2019
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume426 728
Shares Outstanding (in ths.)37 496
Trades Count537
Dollar Volume151 476
Avg. Volume1 976 325
Avg. Weekly Volume854 754
Avg. Monthly Volume1 727 979
Avg. Quarterly Volume1 985 926

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

41%59%

Bearish Bullish

53%47%

Bearish Bullish

67%33%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
1 (100.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
0 (0.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Rating--Strong Buy
1.00

There are no comments yet.

News